These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29530433)

  • 21. Influence of image slice thickness on rectal dose-response relationships following radiotherapy of prostate cancer.
    Olsson C; Thor M; Liu M; Moissenko V; Petersen SE; Høyer M; Apte A; Deasy JO
    Phys Med Biol; 2014 Jul; 59(14):3749-59. PubMed ID: 24936956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional data analysis in NTCP modeling: a new method to explore the radiation dose-volume effects.
    Benadjaoud MA; Blanchard P; Schwartz B; Champoudry J; Bouaita R; Lefkopoulos D; Deutsch E; Diallo I; Cardot H; de Vathaire F
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):654-63. PubMed ID: 25304951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer.
    Cheung R; Tucker SL; Ye JS; Dong L; Liu H; Huang E; Mohan R; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1513-9. PubMed ID: 15050331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy.
    Dale E; Olsen DR; Fosså SD
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):385-91. PubMed ID: 10030266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.
    Fiorino C; Sanguineti G; Cozzarini C; Fellin G; Foppiano F; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):953-62. PubMed ID: 14575825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Principal component analysis-based pattern analysis of dose-volume histograms and influence on rectal toxicity.
    Söhn M; Alber M; Yan D
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):230-9. PubMed ID: 17707277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer.
    Tucker SL; Cheung R; Dong L; Liu HH; Thames HD; Huang EH; Kuban D; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):353-65. PubMed ID: 15145148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.
    Tucker SL; Dong L; Bosch WR; Michalski J; Winter K; Mohan R; Purdy JA; Kuban D; Lee AK; Cheung MR; Thames HD; Cox JD
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1253-60. PubMed ID: 20598811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer.
    Greco C; Mazzetta C; Cattani F; Tosi G; Castiglioni S; Fodor A; Orecchia R
    Radiother Oncol; 2003 Nov; 69(2):215-22. PubMed ID: 14643961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term rectal function after high-dose prostatecancer radiotherapy: results from a prospective cohort study.
    Fellin G; Rancati T; Fiorino C; Vavassori V; Antognoni P; Baccolini M; Bianchi C; Cagna E; Borca VC; Girelli G; Iacopino B; Maliverni G; Mauro FA; Menegotti L; Monti AF; Romani F; Stasi M; Valdagni R
    Radiother Oncol; 2014 Feb; 110(2):272-7. PubMed ID: 24332020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of prediction models for radiation-induced late rectal bleeding: Evidence from a large pooled population of prostate cancer patients.
    Cicchetti A; Fiorino C; Ebert MA; Iacovacci J; Kennedy A; Joseph DJ; Denham JW; Vavassori V; Fellin G; Cozzarini C; Esposti CD; Gabriele P; Munoz F; Avuzzi B; Valdagni R; Rancati T
    Radiother Oncol; 2023 Jun; 183():109628. PubMed ID: 36934896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy.
    Valdagni R; Rancati T; Ghilotti M; Cozzarini C; Vavassori V; Fellin G; Fiorino C; Girelli G; Barra S; Zaffaroni N; Pierotti MA; Gariboldi M
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1431-40. PubMed ID: 19211196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancer.
    Someya M; Hori M; Tateoka K; Nakata K; Takagi M; Saito M; Hirokawa N; Hareyama M; Sakata K
    J Radiat Res; 2015 Jan; 56(1):122-7. PubMed ID: 25212601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.
    Boersma LJ; van den Brink M; Bruce AM; Shouman T; Gras L; te Velde A; Lebesque JV
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):83-92. PubMed ID: 9588921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Avoidance of late rectal toxicity after high-dose-rate brachytherapy boost treatment for prostate cancer.
    Kragelj B; Zlatic J; Zaletel-Kragelj L
    Brachytherapy; 2017; 16(1):193-200. PubMed ID: 27908678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
    Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
    Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer.
    Patel RR; Orton N; Tomé WA; Chappell R; Ritter MA
    Radiother Oncol; 2003 Jun; 67(3):285-94. PubMed ID: 12865176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
    Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
    Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlations between dose-surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer.
    Fenwick JD; Khoo VS; Nahum AE; Sanchez-Nieto B; Dearnaley DP
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):473-80. PubMed ID: 11173143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selection.
    Vanneste BG; Hoffmann AL; van Lin EN; Van De Voorde L; Pinkawa M; Lambin P
    Radiother Oncol; 2016 Oct; 121(1):118-123. PubMed ID: 27647458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.